Nirit Mor-Vaknin

Title: Nirit Mor-Vaknin: Innovator in DEK Protein Research

Introduction

Nirit Mor-Vaknin is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of biomedical research, particularly in the study of DEK protein and its implications in various diseases. With a total of 4 patents, her work focuses on innovative methods for treating inflammatory and autoimmune diseases.

Latest Patents

Nirit's latest patents include groundbreaking inventions such as "Inhibitors of DEK protein and related methods." This invention provides methods of treatment using inhibitors of DEK protein and DEK activity. These methods encompass preventing, treating, and ameliorating inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other conditions associated with DEK. The inhibitors include pharmaceutical compositions featuring single-stranded DNA or RNA aptamers that can bind to DEK. Additionally, these aptamers are useful for diagnosing DEK-related diseases or conditions. Another notable patent is "DEK protein compositions and methods of using the same." This invention relates to DEK protein compositions, including antibodies, small molecule inhibitors, and siRNAs, aimed at treating autoimmune diseases and inhibiting inflammation.

Career Highlights

Nirit Mor-Vaknin is affiliated with the University of Michigan, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential to significantly impact the treatment of autoimmune diseases and related conditions.

Collaborations

Nirit collaborates with esteemed colleagues such as David M Markovitz and Christopher L Hall, enhancing the scope and impact of her research.

Conclusion

Nirit Mor-Vaknin's contributions to the field of DEK protein research exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts position her as a key figure in the ongoing fight against autoimmune diseases.